These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma. Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631 [TBL] [Abstract][Full Text] [Related]
47. AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations. Pacouret S; Bouzelha M; Shelke R; Andres-Mateos E; Xiao R; Maurer A; Mevel M; Turunen H; Barungi T; Penaud-Budloo M; Broucque F; Blouin V; Moullier P; Ayuso E; Vandenberghe LH Mol Ther; 2017 Jun; 25(6):1375-1386. PubMed ID: 28427840 [TBL] [Abstract][Full Text] [Related]
48. Detection of adeno-associated virus DNA in female genital samples by PCR-ELISA. Venturoli S; Cricca M; Bonvicini F; Gallinella G; Gentilomi G; Zerbini M; Musiani M J Med Virol; 2001 Aug; 64(4):577-82. PubMed ID: 11468746 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells. Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336 [TBL] [Abstract][Full Text] [Related]
53. Enhanced transduction of mouse salivary glands with AAV5-based vectors. Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060 [TBL] [Abstract][Full Text] [Related]
54. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors. Du L; Kido M; Lee DV; Rabinowitz JE; Samulski RJ; Jamieson SW; Weitzman MD; Thistlethwaite PA Mol Ther; 2004 Sep; 10(3):604-8. PubMed ID: 15336660 [TBL] [Abstract][Full Text] [Related]
55. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype. Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727 [TBL] [Abstract][Full Text] [Related]
56. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. Grieger JC; Soltys SM; Samulski RJ Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810 [TBL] [Abstract][Full Text] [Related]
57. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443 [TBL] [Abstract][Full Text] [Related]
58. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors. Blits B; Derks S; Twisk J; Ehlert E; Prins J; Verhaagen J J Neurosci Methods; 2010 Jan; 185(2):257-63. PubMed ID: 19850079 [TBL] [Abstract][Full Text] [Related]
59. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512 [TBL] [Abstract][Full Text] [Related]